ERYTECH publie ses résultats financiers et fait le point sur ses activités du premier semestre 2018
September 10, 2018 16:30 ET
|
Erytech Pharma S.A.
Conférence téléphonique et webcast : mardi 11 septembre à 14h30 Confirmation du virage stratégique entrepris vers le développement d’eryaspase dans les tumeurs solidesLancement de l’étude de Phase...
ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update
September 10, 2018 16:30 ET
|
Erytech Pharma S.A.
Conference call and webcast scheduled for Tuesday, September 11that 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmedPhase 3 trial for eryaspase in second...
Kura Oncology to Present at the 2015 Wedbush PacGrow Healthcare Conference
August 05, 2015 07:30 ET
|
Kura Oncology, Inc.
LA JOLLA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...
Semafore Pharmaceuticals to Present SF1126 Clinical Data at ASCO Annual Meeting
May 26, 2011 08:30 ET
|
Semafore Pharmaceuticals
INDIANAPOLIS, May 26, 2011 (GLOBE NEWSWIRE) -- Semafore Pharmaceuticals today announced that Phase 1 clinical data for SF1126 will be presented at the 47th Annual Meeting of the American Society of...